MICAL2 is essential for myogenic lineage commitment
Nefele Giarratana(KU Leuven), Maurilio Sampaolesi(Sapienza University of Rome), Geert Bultynck(Toxicologie, Pharmacologie et Signalisation Cellulaire), Rik Gijsbers(Advanced Pharma), Flavio Ronzoni(University of Pavia), Debora Angeloni(Scuola Superiore Sant'Anna), Tim Vervliet(Toxicologie, Pharmacologie et Signalisation Cellulaire), Paolo Carai(KU Leuven), Domiziana Costamagna(Neuroelectronics Research Flanders), Robin Duelen(KU Leuven), Stefania Fulle(University of Chieti-Pescara), Ivana Barravecchia(Scuola Superiore Sant'Anna), Filippo Conti(Université Claude Bernard Lyon 1), Yvan Torrente(University of Milan), Rita La Rovere(University of Chieti-Pescara), Roberto Piciotti(University of Pavia)
Cited by 28
Related Papers
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
|Cancer Cell|2005|1.3k
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
|Nature Cell Biology|2007|979
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts
|Science|2003|620
Role of Inflammation in Muscle Homeostasis and Myogenesis
|Mediators of Inflammation|2015|535